HopeStage
Back to all studies
CompletedNCT06051721

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

This study evaluated the safety and effectiveness of CYB004 for people with anxiety.

Medication studyAges 18–65United States
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety and effectiveness of CYB004 for people with anxiety.

Who was this study for?

This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Hollywood and 5 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateStarted: May 10, 2024
Recruitment status
Completed
Enrollment listed in the registry
36
Sponsor
Cybin IRL Limited
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06051721
Official title
Show the full official title

A Phase 2a, Randomized, Double-Blind, Active-Controlled Study to Assess the Preliminary Clinical Efficacy, Safety, Tolerability, and Pharmacokinetics, of CYB004 in Participants With Generalized Anxiety Disorder (GAD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Hollywood · Miami Lakes · Atlanta

3 more locations
  • Decatur
  • Chicago
  • Murray
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety and effectiveness of CYB004 for people with anxiety.

Who is behind this study?

The study sponsor is Cybin IRL Limited.

Did this study involve medication?

Yes. The study involved medication, including CYB004.

Who was this study for?

This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me